Your browser doesn't support javascript.
loading
Anti-IgE monoclonal antibodies as potential treatment in COVID-19.
Farmani, Ahmad Reza; Mahdavinezhad, Forough; Moslemi, Rohollah; Mehrabi, Zeinab; Noori, Alireza; Kouhestani, Mahsa; Noroozi, Zahra; Ai, Jafar; Rezaei, Nima.
Afiliação
  • Farmani AR; Tissue Engineering and Applied Cell Sciences Department, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Mahdavinezhad F; Tissue Engineering Department, School of Advanced Technologies in Medicine, Fasa University of Medical Sciences, Fasa, Iran.
  • Moslemi R; Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Mehrabi Z; Anatomy Department-School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Noori A; Department of Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Kouhestani M; Internal Medicine Department, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Noroozi Z; Tissue Engineering and Applied Cell Sciences Department, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Ai J; Tissue Engineering and Applied Cell Sciences Department, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Rezaei N; Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Immunopharmacol Immunotoxicol ; 43(3): 259-264, 2021 Jun.
Article em En | MEDLINE | ID: mdl-34018464
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Omalizumab / COVID-19 / Tratamento Farmacológico da COVID-19 Limite: Humans Idioma: En Revista: Immunopharmacol Immunotoxicol Assunto da revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA / TOXICOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Irã País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Omalizumab / COVID-19 / Tratamento Farmacológico da COVID-19 Limite: Humans Idioma: En Revista: Immunopharmacol Immunotoxicol Assunto da revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA / TOXICOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Irã País de publicação: Reino Unido